Kymanox Executive Advisors (KEAs) Mathias Romacker, Fran DeGrazio, and Paul Jansen sit down with Guy Furness to discuss what has driven Kymanox’s rapid rise in the drug delivery space and what makes the consulting company’s model so successful, as well as to share their expertise on a variety of topics in an illuminating discussion including connectivity, how large and small drug developers engage with consultancies, 5mL autoinjectors, and the interface between drug primary packaging and delivery devices.

Read More